RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @MM_Oncology: #KEYNOTE361 trial of 1L pembrolizumab, with/without chemo, in advanced #UrothelialCancer now published in @TheLancetOncol…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
Pembrolizumab alone or combined with #chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361) https://t.co/slQLre03BY #Cancer
RT @gedefo_sefh: [Articles] Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothe…
[Articles] Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial https://t.co/wHKuMAStAD
RT @TheLancetOncol: Online first: KEYNOTE-361 - #Pembrolizumab alone or combined with #chemotherapy versus chemotherapy as first-line thera…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @TheLancetOncol: Online first: KEYNOTE-361 - #Pembrolizumab alone or combined with #chemotherapy versus chemotherapy as first-line thera…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
Pembrolizumab alone or combined with chemotherapy versus #chemotherapy as first-line therapy for advanced #UrothelialCarcinoma. #CancerTherapy https://t.co/mQLDXGpd4k
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @TheLancetOncol: Online first: KEYNOTE-361 - #Pembrolizumab alone or combined with #chemotherapy versus chemotherapy as first-line thera…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @TheLancetOncol: Online first: KEYNOTE-361 - #Pembrolizumab alone or combined with #chemotherapy versus chemotherapy as first-line thera…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @TheLancetOncol: Online first: KEYNOTE-361 - #Pembrolizumab alone or combined with #chemotherapy versus chemotherapy as first-line thera…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
RT @tompowles1: Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo…
Online first: KEYNOTE-361 - #Pembrolizumab alone or combined with #chemotherapy versus chemotherapy as first-line therapy for advanced #urothelialcarcinoma: a randomised, open-label, phase 3 trial #gucsm #bladdercancer https://t.co/nGaojuJ957
RT @MM_Oncology: #KEYNOTE361 trial of 1L pembrolizumab, with/without chemo, in advanced #UrothelialCancer now published in @TheLancetOncol…
#KEYNOTE361 trial of 1L pembrolizumab, with/without chemo, in advanced #UrothelialCancer now published in @TheLancetOncol 👉https://t.co/DfsBnwi4MN👈 Read our report from #ESMO20 & also watch our interview with study author @AlvaAjjai (@UMich) @uroupdate
Pembro +chemo isn’t additive in UC and the trial was -ve. Data suggests some pembro activity after the chemo stopped. Chemo was initially better than pembro alone but pembro did result in durable remissions, as in KN52. The 22C3 PDL1 biomarker didn’t help.
RT @ABsteward: KEYNOTE-361 RCT #nonIDtwitter @TheLancetOncol The addition of pembrolizumab to first-line platinum-based chemotherapy did no…
KEYNOTE-361 RCT #nonIDtwitter @TheLancetOncol The addition of pembrolizumab to first-line platinum-based chemotherapy did not significantly improve efficacy and should not be widely adopted for treatment of advanced urothelial carcinoma #TwitteRx https://